The long-term objectives of this research group continues to be the investigation of i) neuro(no)trophic factors that support maintenance, growth, function and repair of selected nerve cells, ii) neurite modulating factors that promote (or inhibit) and guide the growth of neuronal axons in development and adult regeneration, and iii) adult rat models that test the competence of neurotrophic and neurite modulating factors to perform in vivo within the context of adult mammalian central and peripheral nervous systems. The underlying expectation -- now widely shared -- is that such factors may ultimately serve as therapeutic tools in degenerative human diseases (e.g. Alzheimer's, Parkinson's, ALS, etc.) and support long-track axonal regeneration after spinal cord or optic nerve lesions, among others. No information is yet available on what trophic and other factors may influence maintenance and repair of corticospinal (CS) motor neurons: the project will address this question by use of both an in vitro model of developing CS cells and an in vivo model of lesioned adult CNS neurons. Another question concerns nerve growth factor (NGF, the prototype for neurotrophic factors), namely the location and identity of NGF producer cells: this project will explore the possible identity between NGF producers and certain subsets of CNS GABAergic neurons. NGF-containing cells have also been found in the hypothalamus and the anterior pituitary, increasing the perception of important links between NGF and thyroid hormones -- and this project will investigate the nature and regulation of hypothalamic and pituitary NGF. Lastly, even when CNS axons are made to regenerate successfully to their innervation territory, the problem remains of what may regulate their distribution there: this project seeks to characterize the newly recognized occurrence of sedimentable NGF in adult brain extracts and the detection of anchored NGF in adult brain sections and to correlate them with pathways and end stations of regenerating cholinergic CNS afferents.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
2R01NS016349-14
Application #
3396834
Study Section
Neurology B Subcommittee 2 (NEUB)
Project Start
1980-03-01
Project End
1996-07-31
Budget Start
1993-08-01
Budget End
1994-07-31
Support Year
14
Fiscal Year
1993
Total Cost
Indirect Cost
Name
University of California San Diego
Department
Type
Schools of Medicine
DUNS #
077758407
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Junger, Heidi; Edelman, David B; Junger, Wolfgang G (2003) Hypertonicity promotes survival of corticospinal motoneurons via mitogen-activated protein kinase p38 signaling. J Mol Neurosci 21:111-20
Hopker, V H; Amoureux, M C; Varon, S (1997) NGF and BDNF in the anterior pituitary lobe of adult rats. J Neurosci Res 49:355-63
Longo, F M; Manthorpe, M; Xie, Y M et al. (1997) Synthetic NGF peptide derivatives prevent neuronal death via a p75 receptor-dependent mechanism. J Neurosci Res 48:1-17
Conner, J M; Lauterborn, J C; Yan, Q et al. (1997) Distribution of brain-derived neurotrophic factor (BDNF) protein and mRNA in the normal adult rat CNS: evidence for anterograde axonal transport. J Neurosci 17:2295-313
Hoener, M C; Varon, S (1997) Reversible sedimentation and masking of nerve growth factor (NGF) antigen by high molecular weight fractions from rat brain. Brain Res 772:1-8
Junger, H; Varon, S (1997) Neurotrophin-4 (NT-4) and glial cell line-derived neurotrophic factor (GDNF) promote the survival of corticospinal motor neurons of neonatal rats in vitro. Brain Res 762:56-60
Hopker, V H; Kjaer, B; Varon, S (1997) Dopaminergic regulation of BDNF content in the pituitary intermediate lobe. Neuroreport 8:1089-93
Conner, J M; Varon, S (1997) Developmental profile of NGF immunoreactivity in the rat brain: a possible role of NGF in the establishment of cholinergic terminal fields in the hippocampus and cortex. Brain Res Dev Brain Res 101:67-79
Conner, J M; Varon, S (1996) Characterization of antibodies to nerve growth factor: assay-dependent variability in the cross-reactivity with other neurotrophins. J Neurosci Methods 65:93-9
Conner, J M (1996) Maintenance of sympathetic innervation into the hippocampal formation requires a continuous local availability of nerve growth factor. Neuroscience 72:933-45

Showing the most recent 10 out of 75 publications